While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...
Cardiotoxicity underlies a third of failures in regulatory clearance, making it among the most significant hurdles in developing new drugs. 1 axoCells human iPSC-derived ventricular cardiomyocytes ...
Researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged heart muscle. The study, published in Circulation ...
Companies transition to supply agreement after two-year evaluation period ends. Cellular Dynamics International (CDI) and Roche report the completion of a two-year collaboration intended to ...
Human heart cells (green-and-red-striped bands in the lower half of the image) grafted into a nonhuman primate heart aside native heart cells (striped red without green). Mixing in the cells that line ...
BEIJING, Jan. 30, 2023 /PRNewswire/ -- Help Therapeutics Co., Ltd. (hereinafter Help Therapeutics) has revealed that the China Center for Drug Evaluation (CDE) has approved the investigational new ...
Human induced pluripotent stem cell (iPSC) technology has significant potential to revolutionize biomedical research. Derived from skin or blood of any individual, iPSCs provide unprecedented access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results